July 8, 2025

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Exploring a 141% Potential Upside in the Biotech Sector

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands out in the biotechnology sector with a promising portfolio of targeted oncology therapeutics. With a market capitalization of $1.85 billion, this precision medicine company..

Alignment Healthcare, Inc. (ALHC) Growth Potential: Analyst Ratings and a 38.68% Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC), a prominent player in the healthcare sector specializing in Medicare Advantage plans, is capturing investor attention with its remarkable growth prospects and analyst optimism. Based..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Navigating Uncharted Territory with a $1.06 Billion Market Cap

Pulse Biosciences, Inc. (NASDAQ: PLSE) stands out in the healthcare sector, specifically within the medical instruments and supplies industry, with its innovative approach to bioelectric medicine. Headquartered in Miami, Florida,..

Certara, Inc. (CERT) Stock Analysis: Navigating a 44% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Certara, Inc. (NASDAQ: CERT) represents an intriguing opportunity, particularly given its potential upside of 44.35% based on the current average..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Exploring the 73.52% Potential Upside in Biotech

For investors with an eye toward the biotechnology sector, Xenon Pharmaceuticals Inc. (NASDAQ: XENE) presents a compelling case, not just for its innovative pipeline but also for its significant potential..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 25% Upside Potential

ANI Pharmaceuticals, Inc. (ANIP) is a standout player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Baudette, Minnesota, this biopharmaceutical company boasts a..

Select Medical Holdings Corp (SEM) Stock Analysis: Eyeing a 38% Potential Upside with Robust Analyst Ratings

Select Medical Holdings Corporation (NYSE: SEM) has emerged as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.9 billion,..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Evaluating the 125% Upside Potential

Investors are always on the lookout for promising opportunities in the healthcare sector, and Dynavax Technologies Corporation (NASDAQ: DVAX) has been catching eyes with its substantial potential upside. With its..

Artivion, Inc. (AORT) Stock Analysis: A Promising Buy With 8% Upside Potential

Artivion, Inc. (AORT), a significant player in the medical devices sector, presents a compelling opportunity for investors seeking growth in the healthcare industry. With a market capitalization of $1.42 billion,..

CONMED Corporation (CNMD) Stock Analysis: Exploring a Potential 28% Upside in the Medical Devices Sector

CONMED Corporation, trading under the ticker CNMD, stands as a noteworthy player in the medical devices sector within the healthcare industry. With a market capitalization of $1.61 billion, this U.S.-based..

Agios Pharmaceuticals (AGIO) Stock Analysis: A 46.87% Upside in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 46.87%, according to analyst ratings. With a current market..

Vera Therapeutics (VERA): Investor Outlook Highlights Potential 175% Upside in Transformative Biotech Arena

Vera Therapeutics, Inc. (NASDAQ: VERA) stands at the forefront of innovation in the healthcare sector, specifically within biotechnology. Based in Brisbane, California, this clinical-stage company focuses on developing transformative treatments..

National HealthCare Corporation (NHC) Stock Analysis: Discovering Growth in Healthcare with a 25.7% Revenue Surge

National HealthCare Corporation (NYSE: NHC) stands out in the healthcare sector, not only for its comprehensive range of services but also for its remarkable revenue growth. With a substantial 25.7%..

QuidelOrtho Corporation (QDEL) Stock Analysis: Potential Upside Amid Healthcare Innovation

QuidelOrtho Corporation (NASDAQ: QDEL), a leading player in the healthcare sector, is making waves with its diagnostic testing solutions. With a market capitalization of $1.98 billion, this medical devices company..

Azenta, Inc. (AZTA) Stock Analysis: Evaluating Its 2.61% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector may want to consider Azenta, Inc. (NASDAQ: AZTA), a key player in the medical instruments and supplies industry. With a market capitalization of $1.44 billion,..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 156% Potential Upside with Robust Analyst Confidence

Mesoblast Limited (MESO), a pioneering entity in the biotechnology sector, stands as a beacon of innovation in the realm of regenerative medicine. Headquartered in Melbourne, Australia, the company is making..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 25.93% Upside in the Healthcare Sector

In the competitive landscape of the healthcare sector, LeMaitre Vascular, Inc. (NASDAQ: LMAT) has carved out a niche in the medical instruments and supplies industry. With a market capitalization of..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Biotechnology Innovator with 139% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE) is capturing the attention of investors with its promising developments in the healthcare sector, specifically in biotechnology. With a market capitalization of $2.29 billion, this..

CG Oncology, Inc. (CGON) Stock Analysis: A 129.84% Potential Upside and Promising Developments in Bladder Cancer Therapeutics

Investors seeking opportunities in the biotechnology sector may want to closely examine CG Oncology, Inc. (CGON), a promising player in the field of bladder cancer therapeutics. With a market capitalization..

Ascentage Pharma Group (AAPG): Navigating Growth Amidst a Complex Biotech Landscape

Ascentage Pharma Group International (AAPG), a burgeoning player in the biotechnology sector, has captured investor attention with its impressive revenue growth and strategic advancements in targeted cancer therapies. Based in..

Search

Funds

July 8, 2025

Search

Funds

July 8, 2025

FTSE 100

Funds